BioMarin Pharmaceutical | BMRN - EPS Earnings Per Share


BioMarin Pharmaceutical reported $0.12 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.77 0.92 Feb/25 2026
FY2025Q3 Sep/2025 0.12 0.86 0.91 Oct/27 2025
FY2025Q2 Jun/2025 1.44 0.84 0.96 Aug/04 2025
FY2025Q1 Mar/2025 1.13 0.65 0.71 May/01 2025
FY2024Q4 Dec/2024 0.92 0.55 0.49 Feb/19 2025




Eps Change Date
Acadia Pharmaceuticals USD 0.42 0.26 Sep/2025
Agios Pharmaceuticals USD -1.78 0.15 Sep/2025
Alnylam Pharmaceuticals USD 2.9 2.58 Sep/2025
Amgen USD 5.29 0.35 Dec/2025
Bayer EUR 0.57 0.66 Sep/2025
Biogen USD 4.81 0.66 Sep/2025
BioMarin Pharmaceutical USD 0.12 1.32 Sep/2025
Gilead Sciences USD 2.47 0.46 Sep/2025
Incyte USD 2.26 0.69 Sep/2025
Insmed USD -1.75 0.05 Sep/2025
Ionis Pharmaceuticals USD -0.8 1.5 Sep/2025
Moderna USD -0.51 1.62 Sep/2025
Neurocrine Biosciences USD 2.17 0.52 Sep/2025
PTC Therapeutics USD 0.2 1.03 Sep/2025
Regeneron Pharmaceuticals USD 11.44 0.39 Dec/2025
Roche Holding CHF 8.37 2.95 Dec/2025
Sanofi EUR -0.67 3.62 Dec/2025
Sarepta Therapeutics USD -0.13 2.15 Sep/2025
Ultragenyx Pharmaceutical USD -1.81 0.64 Sep/2025
United Therapeutics USD 7.16 0.75 Sep/2025
Vertex Pharmaceuticals USD 4.8 0.28 Sep/2025